IOVANCE BIOTHERAPEUTICS, INC.: capex
| Value | {"amount": 33836000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | IOVANCE BIOTHERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:00:10.220946+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/41f3030b-f820-45cb-8b1d-f1b1ec664613
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-26-018899Retrieved: 2026-08-19T14:00:10.220946+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001425205/capex/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/41f3030b-f820-45cb-8b1d-f1b1ec664613
History
- no predecessors — first report